Search research articles
Contact Us
Filters
Showing results (871-880 of 920) with videos related to
Page
of 92
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530
D Dubé, M Blouin, C Brideau, et al.
Neurology
|
October 1, 2010
Changes in fiber tract integrity and visual fields after anterior temporal lobectomy
C R McDonald, D J Hagler, H M Girard, et al.
AIDS Research and Human Retroviruses
|
May 12, 2010
Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal
Roland Landman, M B Diallo, N F Ngom Gueye, et al.
Oncotarget
|
February 1, 2019
Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
Roberto Carmagnani Pestana, Manal M Hassan, Reham Abdel-Wahab, et al.
Plos One
|
May 31, 2024
A comprehensive protocol for quantitative magnetic resonance imaging of the brain at 3 Tesla
Dvir Radunsky, Chen Solomon, Neta Stern, et al.
Lancet (London, England)
|
July 25, 2006
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial
, P Yeni, D A Cooper, et al.
Antimicrobial Agents and Chemotherapy
|
May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients
Lucile Larrouy, C Chazallon, R Landman, et al.
Pediatric Blood & Cancer
|
July 9, 2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01
Deborah P Waber, Marie McCabe, Mikaela Sebree, et al.
HIV Medicine
|
September 1, 2007
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach
Y Yazdanpanah, M Vray, J Meynard, et al.
Journal of Medical Virology
|
December 26, 2015
Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal
O Ndiaye, J Gozlan, H Diop-Ndiaye, et al.
Page
of 92
Search research articles
Search
Showing results (871-880 of 920) with videos related to
Sort By:
Page
of 92
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530
D Dubé, M Blouin, C Brideau, et al.
Neurology
|
October 1, 2010
Changes in fiber tract integrity and visual fields after anterior temporal lobectomy
C R McDonald, D J Hagler, H M Girard, et al.
AIDS Research and Human Retroviruses
|
May 12, 2010
Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal
Roland Landman, M B Diallo, N F Ngom Gueye, et al.
Oncotarget
|
February 1, 2019
Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
Roberto Carmagnani Pestana, Manal M Hassan, Reham Abdel-Wahab, et al.
Plos One
|
May 31, 2024
A comprehensive protocol for quantitative magnetic resonance imaging of the brain at 3 Tesla
Dvir Radunsky, Chen Solomon, Neta Stern, et al.
Lancet (London, England)
|
July 25, 2006
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial
, P Yeni, D A Cooper, et al.
Antimicrobial Agents and Chemotherapy
|
May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients
Lucile Larrouy, C Chazallon, R Landman, et al.
Pediatric Blood & Cancer
|
July 9, 2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01
Deborah P Waber, Marie McCabe, Mikaela Sebree, et al.
HIV Medicine
|
September 1, 2007
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach
Y Yazdanpanah, M Vray, J Meynard, et al.
Journal of Medical Virology
|
December 26, 2015
Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal
O Ndiaye, J Gozlan, H Diop-Ndiaye, et al.
Page
of 92